Site-Specific Factor 3

International Prognostic Index (IPI)


**Note 1:** The International Prognostic Index (IPI) has been developed for lymphomas and predicts outcome based on the following adverse factors * Age greater than or equal to 60 years * Ann Arbor Stage III or IV * More than 1 extranodal site involved * Patient's performance status (Eastern Cooperative Oncology Group, ECOG) 2, 3, or 4 * Elevated serum lactate dehydrogenase (LDH) level **Note 2:** Record the IPI as stated in the medical record. Do not calculate points or assign risk. Only record points or risk if a physician has documented them. Use points over risk if both are available. **Note 3:** There are now three indices/scores associated with lymphoma * The International Prognostic Index (IPI) (**Site-Specific Factor 3**) * The Follicular Lymphoma International Prognostic Index (FLIPI) (**Site-Specific Factor 4**) * The International Prognostic Score (IPS- for Hodgkin lymphomas) (**Site-Specific Factor 5**) Physicians may use these indices/scores interchangeably. For coding * Score identified: Value in appropriate SSF, 999 in other two SSFs * Score not identified, point value 5 or less: 999 in all three SSFs * Score not identified, point value 6 or 7: Value in SSF 5 (IPS), 999 in other two SSFs




NAACCR #2900


Code Description
000 0 points
001 1 point
002 2 points
003 3 points
004 4 points
005 5 points
988 Not applicable: Information not collected for this case
990 Stated as low risk (0-1 point)
991 Stated as low intermediate risk (2 points)
992 Stated as intermediate risk (3 points)
993 Stated as high risk (4-5 points)
999 Unknown or no information
Not documented in patient record